Our Team

Meet Our Team:
Industry Leaders in Stroke Treatment

Our leadership team brings deep industry expertise and a strong global track record across pharmaceutical and biotechnology companies. With combined experience of over 50 years in the industry, they have played a key role in advancing therapies forward.
Dr. Sandeep Athalye
Dr. Athalye serves as the Chief Executive at Prolong, where he oversees the company's strategic direction and operations, leveraging his extensive background in clinical development, regulatory strategy, and R&D.
Viet Nguyen
Viet serves as the Chief Operations Officer at Prolong, where he oversees Quality Management, Operations, and Biosimilar Development.
Dr. Ron Jubin
Dr. Jubin serves as the Vice President of Research and Development at Prolong, bringing over 20 years of experience in drug discovery and innovation.
Dr. Kirsten Gruis
Dr. Gruis serves as the Chef Medical Officer at Prolong, bringing in over 15 years of experience in academia, pharmaceuticals, and biotechnology.
John Pakulski
John serves as the Head of Regulatory Affairs at Prolong, bringing in over 35 years of experience in regulatory strategy and compliance.
Dr. Shaunak Pandya
Dr. Pandya serves as the Director of CMC, R&D at Prolong, where he leads phase-appropriate product development for biologics programs.

Meet the Medical Advisory Board

Chairman
Dr. Italo Linfante

Director of Interventional Neuroradiology, Baptist Health Miami Neuroscience Institute

Member
Dr. Raul Nogeuira

Director, UPMC Stroke Institute, University Pittsburgh Medical Center

Member
Dr. David Liebeskind

Director, UCLA Stroke Center

Member
Dr. Arvind Sharma

Neurologist, Stroke Specialist

Prolong’s Path to Success

Our Investors

Avtar Investments is a single-family office with extensive experience investing in healthcare assets, including pharmaceuticals, health technology, and healthcare services.
visit their website
Tarsadia is an institutional single-family office with a permanent capital base, built on deep domain expertise, opportunistic flexibility, and disciplined investment principles.
visit their website

Be part of Our journey

Join us in advancing treatments for severe and life-threatening conditions.
call us
or
email our team
Address
300 Corporate Court, Suite B
South Plainfield, NJ 07080 USA
Phone
(908) 444-4660 direct
(908) 444-4661 fax
Email
info@prolongpharma.com
About Us
Meet ProlongManagement TeamMedical Advisory BoardOur Investors
Sanguinate®
PipelineHow it WorksGlobal Strokes FactsClinical Trials
Resources
PublicationsConferencesNewsReferences
Legal
Copyright Notice
Terms & Conditions
Privacy Policy
Expanded Access Policy
Prolong Pharmaceuticals, LLC does not provide any investigational drugs to patients outside of participation in an active clinical trial. For more information on our ongoing clinical trials, please contact info@prolongpharma.com.